Clinical Trial Update: A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease. [Phase 2]

View source ↗

Summary

Phase IIa clinical trial of TSG-01 in chronic heart failure due to coronary heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Heart Failure

Drugs mentioned

• TSG-01

Snippet

Sponsor: Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd. | Conditions: Chronic Heart Failure | Phase 2 | Status: COMPLETED